Literature DB >> 17222482

BDNF genotype potentially modifying the association between incident stroke and depression.

Jae-Min Kim1, Robert Stewart, Sung-Wan Kim, Su-Jin Yang, Il-Seon Shin, Young-Hoon Kim, Jin-Sang Yoon.   

Abstract

OBJECTIVE: To investigate the role of the brain-derived neurotrophic factor (BDNF) gene val66met polymorphism in the association between stroke and depression.
METHOD: Five hundred community residents aged >65 years without stroke or depression at baseline were re-evaluated after 2 years. Disability (World Health Organization Disability Assessment Schedule, WHODAS II), cognitive function (Mini-Mental State Examination, MMSE), and BDNF genotype were also measured at baseline.
RESULTS: The association between incident stroke and depression was strengthened progressively with increasing numbers of met alleles, and was only significant in subjects with the met/met genotype after adjustment for disability and cognitive function.
CONCLUSION: The BDNF val66met polymorphism may modify the association between stroke and depression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222482     DOI: 10.1016/j.neurobiolaging.2006.11.021

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  21 in total

1.  The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis.

Authors:  Yu Pei; Alicia K Smith; Yongjun Wang; Yanli Pan; Jian Yang; Qi Chen; Weigang Pan; Feng Bao; Lisha Zhao; Changle Tie; Yizheng Wang; Jian Wang; Wenfeng Zhen; Jinxia Zhou; Xin Ma
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-18       Impact factor: 3.568

Review 2.  New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases.

Authors:  Naoki Adachi; Tadahiro Numakawa; Misty Richards; Shingo Nakajima; Hiroshi Kunugi
Journal:  World J Biol Chem       Date:  2014-11-26

3.  The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression.

Authors:  Sophiya Benjamin; Douglas R McQuoid; Guy G Potter; Martha E Payne; James R MacFall; David C Steffens; Warren D Taylor
Journal:  Am J Geriatr Psychiatry       Date:  2010-04       Impact factor: 4.105

4.  A Load to Find Clinically Useful Biomarkers for Depression.

Authors:  Matea Nikolac Perkovic; Marina Sagud; Lucija Tudor; Marcela Konjevod; Dubravka Svob Strac; Nela Pivac
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Neuroplasticity in the context of motor rehabilitation after stroke.

Authors:  Michael A Dimyan; Leonardo G Cohen
Journal:  Nat Rev Neurol       Date:  2011-01-18       Impact factor: 42.937

6.  Interaction between the BDNF gene Val/66/Met polymorphism and morning cortisol levels as a predictor of depression in adult women.

Authors:  J Herbert; M Ban; G W Brown; T O Harris; A Ogilvie; R Uher; T K J Craig
Journal:  Br J Psychiatry       Date:  2012-07-26       Impact factor: 9.319

Review 7.  Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Authors:  Jonathan Savitz; Wayne C Drevets
Journal:  Neurosci Biobehav Rev       Date:  2009-01-21       Impact factor: 8.989

Review 8.  Impact of genetic variant BDNF (Val66Met) on brain structure and function.

Authors:  Zhe-Yu Chen; Kevin Bath; Bruce McEwen; Barbara Hempstead; Francis Lee
Journal:  Novartis Found Symp       Date:  2008

9.  Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham Study.

Authors:  Aleksandra Pikula; Alexa S Beiser; Tai C Chen; Sarah R Preis; Demetrios Vorgias; Charles DeCarli; Rhoda Au; Margaret Kelly-Hayes; Carlos S Kase; Philip A Wolf; Ramachandran S Vasan; Sudha Seshadri
Journal:  Stroke       Date:  2013-08-08       Impact factor: 7.914

10.  Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment.

Authors:  Francis E Lotrich; Salwa Albusaysi; Robert E Ferrell
Journal:  Neuropsychopharmacology       Date:  2012-12-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.